We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Sponsor content
356 result(s) found, displaying 281 to 290
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELMETIA 50/850 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 850 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELMETIA XR 50/500 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 500 mg modified release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELMETIA XR 50/1000 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride1000 mg modified release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELMETIA XR 100/1000 sitagliptin(as phosphate monohydrate) 100 mg and metformin hydrochloride 1000 mg modified release tablet bottle.
-
Prescription medicine registrationActive ingredients: ezetimibe.
-
Prescription medicine registrationActive ingredients: pembrolizumab (rch).
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Designation or determinationOrphan drug
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PNEUMOVAX 23 pneumococcal purified capsular polysaccharides 25 microgram/0.5mL injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JANUMET XR 50/1000 sitagliptin (as phosphate monohydrate)/metformin hydrochloride 50 mg/1000 mg extended release tablet bottle.